AAAAAA
Results:
1-9
|
Results: 9
Authors:
SPREAT S
CONROY J
Citation: S. Spreat et J. Conroy, USE OF PSYCHOTROPIC MEDICATIONS FOR PERSONS WITH MENTAL-RETARDATION WHO LIVE IN OKLAHOMA NURSING-HOMES, Psychiatric services, 49(4), 1998, pp. 510-512
Authors:
SPREAT S
CONROY JW
RICE DMM
Citation: S. Spreat et al., IMPROVE QUALITY IN NURSING-HOMES OR INSTITUTE COMMUNITY PLACEMENT - IMPLEMENTATION OF OBRA FOR INDIVIDUALS WITH MENTAL-RETARDATION, Research in developmental disabilities, 19(6), 1998, pp. 507-518
Authors:
BEHAR D
SCHALLER J
SPREAT S
Citation: D. Behar et al., EXTREME REDUCTION OF METHYLPHENIDATE LEVELS BY CARBAMAZEPINE, Journal of the American Academy of Child and Adolescent Psychiatry, 37(11), 1998, pp. 1128-1129
Authors:
SPREAT S
CONROY JW
JONES JC
Citation: S. Spreat et al., USE OF PSYCHOTROPIC MEDICATION IN OKLAHOMA - A STATEWIDE SURVEY, American journal of mental retardation, 102(1), 1997, pp. 80-85
Authors:
SPREAT S
CONNELLY L
Citation: S. Spreat et L. Connelly, RELIABILITY-ANALYSIS OF THE MOTIVATION ASSESSMENT SCALE, American journal of mental retardation, 100(5), 1996, pp. 528-532
Authors:
SPREAT S
WALSH DE
Citation: S. Spreat et De. Walsh, THE ACCEPTABILITY OF TREATMENT ACCEPTABILITY RESEARCH, MENTAL RETA, 33(1), 1995, pp. 58-59
Authors:
SPREAT S
WALSH DE
Citation: S. Spreat et De. Walsh, IMPACT OF TREATMENT EFFICACY AND PROFESSIONAL AFFILIATION ON RATINGS OF TREATMENT ACCEPTABILITY, MENTAL RETA, 32(3), 1994, pp. 227-233
Authors:
SPREAT S
BEHAR D
Citation: S. Spreat et D. Behar, TRENDS IN THE RESIDENTIAL (INPATIENT) TREATMENT OF INDIVIDUALS WITH ADUAL DIAGNOSIS, Journal of consulting and clinical psychology, 62(1), 1994, pp. 43-48
Authors:
SPREAT S
SERAFIN C
BEHAR D
LEIMAN S
Citation: S. Spreat et al., TRANQUILIZER REDUCTION TRIALS IN A RESIDENTIAL PROGRAM FOR PERSONS WITH MENTAL-RETARDATION, Hospital & community psychiatry, 44(11), 1993, pp. 1100-1102
Risultati:
1-9
|